Position in INO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$8,908
-$938 QoQ
Shares Held
5,120
-9.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Covestor Ltd holds $3,313,348 across 163 Biotechnology names. INO ranks #47 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRTA |
Prothena Corp Public Ltd Co
|
32,657 | $317,426 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,840 | $276,190 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
8,219 | $203,502 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
303 | $135,301 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
2,073 | $117,103 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
133 | $102,761 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,376 | $102,181 | |
| 8 | ABVX |
Abivax S.A.
|
891 | $99,212 |
All Filings in INO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,908 | 5,120 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $9,846 | 5,659 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,242 | 5,659 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,802 | 1,864 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,043 | 1,867 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,705 | 932 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,387 | 240 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,092 | 259 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,594 | 259 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||